Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.910
-0.180 (-4.40%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Genelux Market Cap
Genelux has a market cap or net worth of $146.00 million as of September 18, 2025. Its market cap has increased by 97.29% in one year.
Market Cap
146.00M
Enterprise Value
119.73M
1-Year Change
97.29%
Ranking
Category
Stock Price
$3.91
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has increased from $141.69M to $146.00M, an increase of 3.04%. That is a compound annual growth rate of 1.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 146.00M | 81.39% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |